The US Food and Drug Administration (FDA) has approved Mimrylo [...]

AC Immune has outlined a series of clinical milestones expected [...]

GlobalData has identified Takeda’s oveporexton FDA decision as one of [...]

The AI Structural Biology (AISB) Network, powered by Apheris GmbH, [...]

Data presented at ISTH 2025 highlight potential for improved outcomes [...]

Takeda’s antibody-drug conjugate gains second frontline indication following positive Phase [...]

Protagonist and Takeda have shared full 32-week results from the [...]